Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Long-Term Investments (2016 - 2025)

Icu Medical's Long-Term Investments history spans 9 years, with the latest figure at $131.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 4231.34% year-over-year to $131.6 million, compared with a TTM value of $131.6 million through Dec 2025, up 4231.34%, and an annual FY2025 reading of $131.6 million, up 4231.34% over the prior year.
  • Long-Term Investments for Q4 2025 was $131.6 million at Icu Medical, down from $134.1 million in the prior quarter.
  • The five-year high for Long-Term Investments was $134.1 million in Q3 2025, with the low at $516000.0 in Q4 2022.
  • Average Long-Term Investments over 4 years is $37.8 million, with a median of $5.9 million recorded in 2021.
  • Year-over-year, Long-Term Investments tumbled 88.83% in 2022 and then soared 4231.34% in 2025.
  • Tracing ICUI's Long-Term Investments over 4 years: stood at $4.6 million in 2021, then tumbled by 88.83% to $516000.0 in 2022, then skyrocketed by 488.76% to $3.0 million in 2024, then soared by 4231.34% to $131.6 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Long-Term Investments are $131.6 million (Q4 2025), $134.1 million (Q3 2025), and $131.6 million (Q2 2025).